SANTA CLARA, Calif., Dec. 10 /PRNewswire/ -- Applied Imaging Corp.
(Nasdaq: AICX) today announced the appointment of Michael A. Zoccoli, Ph.D. to
the position of Vice President of Product Development for the Company. As
Vice President of Product Development, Dr. Zoccoli will initially be
responsible for fetal cell maternal blood consumables development. Dr.
Zoccoli will report to Michael Burgett, Ph.D., President, Genetic Diagnostics
Division and Executive Vice President of the Company.
Michael Zoccoli has fifteen years of industry experience in biotechnology
and diagnostic product research, development, transfer to manufacturing and
product launch. Prior to joining Applied Imaging, Dr. Zoccoli served as
Director of PCR Systems Research and Development for Roche Molecular Systems,
Inc. From 1991 to 1997, he served in various capacities at Roche responsible
for development of PCR products for research and diagnostic use.
"We are very pleased that Dr. Zoccoli has joined the Applied Imaging team.
Mike's experience in product development, program management, and transfer of
products to manufacturing will greatly benefit the Company's fetal cell
program and other future plans," said Dr. Jack Goldstein, CEO of the Company.
Dr. Zoccoli received his Ph.D. in Chemistry/Biochemistry from Dartmouth
College, and currently resides in Moraga, California.
Applied Imaging Corporation develops, manufactures and markets automated
clinical analysis systems used by laboratories for the diagnosis of prenatal
and other genetic disorders. The Company markets its products worldwide.
Applied Imaging is developing a proprietary prenatal test for screening of
genetic abnormalities by isolating fetal cells from a routine maternal sample.
This new test is designed to improve current prenatal screening techniques by
providing an accurate and cost effective procedure without the risk of
miscarriage associated with invasive prenatal testing.
For additional information on Applied Imaging via fax, please dial
800-PRO-INFO, or 908-544-2850 outside of the U.S., code AICX.
SOURCE Applied Imaging Corp.
 back to top
CONTACT:
Donna C. Dickinson, Investor Relations of
Applied Imaging Corporation, 408-562-0250; or General
Information, Paula Berg, or analyst, Kate Rajeck, both of
Financial Relations Board, 415-986-1591, for Applied Imaging
Corporation
|
